As the DG75 Burkitt’s lymphoma cell line not only expresses a membrane-anchored BCR but also secretes soluble Ig, we evaluated the serum levels of the scFull-Ig as a biomarker of the tumor mass, similar to the serum monoclonal Ig components paralleling tumor growth in myeloma patients (Figure 7B). This evidence concerns the gene BCR and plasma cell myeloma.